Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 201075

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2022 | Month : August | Volume : 16 | Issue : 8 | Page : EC52 - EC55 Full Version

Micronucleus Scoring in Fine Needle Aspiration Cytology of Breast Lesions- A Retrospective Analytical Study


Published: August 1, 2022 | DOI: https://doi.org/10.7860/JCDR/2022/49784.16810
Ramya Katta, Kakumanu Nageswara Rao, Badugu Krishna Murthy, Shaik Raja Husne Kalam

1. Assistant Professor, Department of Pathology, Guntur Medical College, Guntur, Andhra Pradesh, India. 2. Associate Professor, Department of Pathology, ACSR Government Medical College, Nellore, Andhra Pradesh, India. 3. Assistant Professor, Department of Pathology, SV Medical College, Tirupathi, Andhra Pradesh, India. 4. Associate Professor, Department of Pathology, ACSR Government Medical College, Nellore, Andhra Pradesh, India.

Correspondence Address :
Ramya Katta,
203, Sai Nilaya, Nelson Mandela Park Road, LIC Colony,
Vijayawada, Andhra Pradesh, India.
E-mail: drkattaramya@gmail.com

Abstract

Introduction: Micronuclei and other nuclear abnormalities are biological indicators of genotoxicity and chromosomal instabilities. Breast lesions are frequently encountered in routine clinical practice and Fine Needle Aspiration Cytology (FNAC) is used as a routine diagnostic modality.

Aim: To identify the utility of micronucleus scoring in classifying and diagnosing palpable breast lesions with FNAC.

Materials and Methods: The present study was a two year retrospective analysis in the Department of Pathology of Guntur Medical College and Government General Hospital, Guntur, Andhra Pradesh. Case records and FNAC smears of breast lesions in the period from March 2018 to February 2020 were retrieved from the departmental archives. Data was analysed in the month of September 2020. A total of 108 cases were included in the study. Micronucleus scoring was done on the FNAC smears independently by two institutional pathologists who were blinded to clinical data and final diagnosis and mean micronuclear scores were obtained. Statistical analysis was done using Chi-square test on Statistical Package of the Social Sciences (SPSS) software (version 14) to determine the significance of micronuclear score in differentiating benign and malignant lesions, and in grading the malignant tumours.

Results: All the cases were classified into four categories: benign, atypical favouring benign, suspicious of malignancy, invasive breast carcinoma on cytology. In the present study it was found that micronucleus scoring was effective in differentiating various benign and malignant breast lesions (p-value=0.0001) and also in grading of malignant tumours (p-value=0.05). The results obtained showed that there exists a significant level of correlation with other well established standard grading systems (Pearson correlation coefficient=0.94).

Conclusion: The present study revealed that micronucleus scoring is indeed a useful and reliable method for diagnosing breast lesions and can be used as an adjunct in classifying difficult and borderline cases on cytology.

Keywords

Biomarkers, Chromosomal instability, Diagnostic method, Genotoxicity

Micronuclei and other nuclear abnormalities are biological indicators of genotoxicity and chromosomal instabilities (1). One of the first acknowledged micronuclei are Howell Jolly bodies that are seen in erythrocytes of patients suffering from nutritional deficiencies of folate and cyanocobalamin (1). The causes of micronucleus formation can vary from being spontaneous, infective, chronic inflammatory, metabolic, genotoxic chemical and radiation exposure, neoplastic and genetic as described in various studies (1),(2). Micronuclei are derived most commonly from acentric chromosomal fragments or from a lagging whole chromosome during the anaphase of mitotic cell division (3),(4),(5). There are various theories postulating the origin of micronucleus like dysfunctional mitotic spindle apparatus formation of dicentric chromatids, ring chromosomes and united sister chromatids (6),(7). These omitted chromosomes ultimately get enclosed by a nuclear membrane and remain within the cytoplasm of the parent cell. Thus, they remain morphologically analogous to normal nuclei, except for the smaller size (ranging between 1/3rd and 1/16th of the nucleus), when stained by conventional smears (8).

The International Human Micronucleus Project launched in 1997 has proved behind doubt that micronuclear assays are minimally invasive and simple indicators of genomic instability (9). Hence, Micronucleus scoring (MN score) studies done in various preneoplastic and neoplastic lesions of oral, cervical, hepatic and urothelial regions have shown that there exists a clear cut correlation between degree of malignancy and MN score (5),(10),(11),(12).

In most micronucleus studies of patients with breast lesions, spontaneous micronuclei of lymphocytes from peripheral blood or exfoliated squamous cells from buccal smears were studied (13),(14). There are only a few studies about occurrence of micronuclei in breast aspirates and its correlation with the type of lesion and grading of tumours (15),(16),(17). Hence, the objective of the present study was to establish if there exists a correlation between micronucleus scoring and epithelial breast lesions (benign and malignant) and to find if this scoring can be used as an adjunct to classify challenging borderline cases. Additionally, correlation between micronuclear score with Robinson’s cytological scoring system grades of malignant lesions was also done (18).

Material and Methods

The present retrospective analytical study was conducted in the Department of Pathology of a tertiary care centre in the month of September 2020 by retrieving data of 24 months period (March 2018 to February 2020). Ethical clearance was taken as per the Institutional protocol (Approval No. Faculty/525/20, Dr. PSIMS and RF- IEC). All fine needle aspiration smears of breast pathology, relevant clinical details and histopathologic reports were retrieved from the departmental archives.

Inclusion criteria: Cases diagnosed as epithelial lesion of the breast with good quality staining, histopathological correlation and relevant clinical details were included in the study.

Exclusion criteria: Fibrocystic disease, abscesses, non epithelial malignancies, cases with no histopathological correlation and smears with poor staining, obscuring elements or degenerated cells were excluded from the study.

Study Procedure

Giemsa stained cytological smears prepared from breast lesion aspirations were studied using binocular microscope (Olympus CX21i). Micronucleus counting was done for all cases using oil immersion objective (100X magnification) by two individual qualified pathologists, following the standard criteria as described by Patino-Garcia B et al., (19). A minimum of 1000 epithelial cells were counted using zigzag method and the scores were given as number per 1000 cells. Areas with overlapping nuclei were avoided to evade false positives. Both the pathologists were blinded to the final diagnosis, in order to avoid confirmation bias. The interobserver reliability was excellent (Cohen’s kappa value: 0.8). Mean of the two blinded observers was considered as the final value of micronucleus score.

Cases were classified into four categories (benign, atypical favouring benign, suspicious of malignancy, invasive breast carcinoma) on cytology after confirmation with their final histopathological diagnosis (20). Mean micronucleus scores for each category were calculated separately. Invasive breast carcinomas (category 4) were categorised into three grades based on Robinson’s cytological scoring and grading system (18). This system uses six cytological parameters (cell dissociation, cell size, cell uniformity, nucleolus, nuclear margin and nuclear chromatin) for grading the invasive breast carcinomas. Each parameter is given a score between 1-3, and the scores are added up to determine the grade of the tumor. Tumours with sum of 6-11 are graded as grade I, sum between 12-14 are graded as grade II tumours and sum between 15-18 are graded as grade III tumours. The degree of correlation between micronucleus scores and Robinson’s grades was also established.

Statistical Analysis

Data was charted using Microsoft Excel (2015 version) and analysed using SPSS software (version 14). Chi-square test was used for calculating value of significance. p-value of less than or equal to 0.05 was taken as significant. Cohen’s kappa value was used to calculate the interobserver reliability. Pearson’s correlation test was used to compare micronuclear scores with Robinson’s cytological grading system.

Results

A total of 108 cases which fit into the inclusion and exclusion criteria were taken into the study. All the cases were classified into four categories: benign, atypical favouring benign, suspicious of malignancy, invasive breast carcinoma on cytology. The case distribution, final histopathological diagnosis, mean age distribution, mean micronucleus scores are depicted in the (Table/Fig 1).

Round to oval, small (diameter size 1/3rd to 1/16th of nucleus), non refractile, intracytoplasmic bodies with smooth contour, colour and texture similar to that of the nucleus were counted as micronuclei (Table/Fig 2).

All invasive breast carcinomas were sub categorised using Robinsons grading system and further correlated with subsequent histological grades as depicted in the (Table/Fig 3). With the application of Chi-square test, it was found that micronucleus scoring can be used effectively in differentiating various benign and malignant breast lesions (p-value=0.001) as depicted in (18) (Table/Fig 4). However, it was found that micronucleus scoring may not be as effective in distinguishing category 1 and category 2 (p-value=0.22) and category 3 and invasive breast carcinoma grade I (p-value=0.12), as depicted in the (Table/Fig 4). As depicted in a significant p-value was obtained on comparing micronucleus scores with Robinsons cytological scoring in the invasive breast carcinoma category (p-value=0.05) (Table/Fig 5). The level of correlation between micronucleus score and Robinsons score was established using Pearson’s correlation coefficient, which showed that there was significant level of correlation between them (0.94).

Discussion

With the evolution of tumour genetics, various genes have been implicated in breast carcinogenesis. Of note are Breast cancer gene 1 (BRCA1) and Breast cancer gene 2 (BRCA2) gene products which play an important role in initiation and/or progression of inherited as well as sporadic cases of breast carcinogenesis (21). It has been shown in various studies that these two gene products along with RAD51 (DNA repair protein), BRCA1-Associated Ring Domain protein 1 (BARD1), p53 and Retinoblastoma (RB) proteins play an important role in centrosome formation (22) and control of chromosome segregation (23),(24),(25). Thus, defective centrosomes that are formed as result of decreased BRCA1 or BRCA2 gene expression result in loss of integrity of chromosome segregation and non dysjunctional chromosomal loss or gain and spontaneous micronuclei formation (26). Thus, micronucleus scoring in breast carcinoma can be used as a simple morphological biomarker for chromosomal breakage and genomic instability and may be used as a screening test (15).

In the present study, it was found that micronucleus scores are significantly different in various benign and malignant lesions and also in various grades of malignant lesions of the breast (Table/Fig 5). The findings of the present study are in concordance with various other studies (15),(16),(17). Thus use of micronucleus scoring in routine practice can be helpful in guiding some difficult diagnoses. As depicted in (Table/Fig 5) there is a gradual increase in the mean micronucleus scores in various grades of invasive breast carcinoma (category 4) with a significant correlation between the micronucleus scores and Robinson’s cytological scoring system. This observation points to the fact that micronucleus scores can be used as an additional criteria in sub categorising difficult malignant lesions of the breast. These results are concordant with those obtained by Samantha S et al., (27).

In the study by Meel M et al., mean micronucleus score >6 predicted the presence of invasive breast carcinoma with a high sensitivity and specificity (28). However, in the present study, it was concluded that differentiation of borderline cases (category 3) from grade I invasive carcinomas by just using micronucleus score may not be reliable. The mean micronucleus scores in the present study were similar to the results of Samantha S et al., study and are much lesser than that obtained in the study of Hemalatha A et al., and are higher than that obtained in Meel M et al., study (15),(27),(28). This variation could be due to varying micronucleus number in baseline cases (benign category).

In the present study micronucleus evaluation was done using routine Giemsa stained slides. Several authors acclaimed that use of Deoxyribonucleic acid (DNA) specific feulgen stain, fluorescent stains like auramine rhodamine stain, propium iodide stain yield better results as false positivity can be evaded (29),(30). However, DNA specific stains like MGG are much cost effective, less cumbersome procedures and are routinely used in normal cytology and hence are preferred (15).

Micronucleus scoring is relatively easy, reliable and reproducible test. However, phagocytosed platelets, karyorrhectic debris of apoptotic cells, smearing and staining artifacts can give rise to increased number of false positives. Use of liquid based cytology, which provides excellent single cell thickness smears and automatic micronuclear counters, may provide more reliable data (1).

Limitation(s)

In the present study, baseline levels of micronucleus scores, its variation with age, sex, exposure to chemicals and other factors were not considered.

Conclusion

The rising use of adjuvant and neoadjuvant therapy in the treatment of invasive breast carcinomas has resulted in increased demand for exploration of more cost effective and simple prognostic biomarkers that can be performed in less sophisticated laboratories. Micronucleus scoring could be a pace towards it.

References

1.
Samanta S, Dey P. Micronucleus and its applications. Diagnostic Cytopathology. 2010;40:84-90. [crossref] [PubMed]
2.
Fenech M, Kirsch Volders M, Natarajan AT, Surralles J, Crott JW, Parry J, et al. Molecular mechanism of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis. 2011;26(1):125 32. [crossref] [PubMed]
3.
Falck GC, Catala NJ, Norppa H. Nature of anaphase laggards and micronuclei in female cytokinesis blocked lymphocytes. Mutagenesis. 2002;17(2):111-17. [crossref] [PubMed]
4.
Ford JH, Schultz CJ, Correll AT. Chromosome elimination in micronuclei: A common cause ofhypoploidy. Am J Hum Genet. 1988;43:733-40.
5.
Guido M, Fassan M, Giacomelli L, Cillo U, Farinati F, Burra P, et al. Micronuclei and broken eggs in human liver carcinogenesis. Anticancer Research. 2008;28:2507-12.
6.
Cimini D, Fioravanti D, Salmon ED, Degrassi F. Merotelic kinetochore orientation versus chromosome mono-orientation in the origin of lagging chromosomes in human primary cells. J Cell Sci. 2002;115:507-15. [crossref] [PubMed]
7.
Saunders WS, Shuster M, Huang X, Gharaibeh B, Enyenihi AH, Petersen I, et al. Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc Natl Acad Sci U S A. 2000;97(1):303-08. [crossref] [PubMed]
8.
Bonassi S, El-Zein R, Bolognesi C, Fenech M. Micronuclei frequency in peripheral blood lymphocyte and cancer risk: Evidence from human studies. Mutagenesis. 2011;26(1):93-100. [crossref] [PubMed]
9.
Fenech M, Holland N, Chang WP, Zeiger E, Bonassi S. The human micronucleus project-An International collaborative study on use of micronucleus for measuring DNA damage in Humans. Mut Res. 1999;428:271-83. [crossref] [PubMed]
10.
Delfino V, Casartelli G, Garzoglio B, Scala M, Mereu P, Bonatti S, et al. Micronuclei and p53 accumilations in preneoplastic and malignant lesions of head and neck. Mutagenesis. 2002;17:73 77. [crossref] [PubMed]
11.
Samanta S, Dey P, Nijhawan R. Micronucleus in cervical intraepithelial lesions and carcinoma. Acta Cytol. 2011;55:42-47. [crossref] [PubMed]
12.
Espinoza F, Cecchini L, Morote J, Marcos R, Pastor S. Micronuclei frequency in urothelial cells of bladder cancer patients, as a biomarker of prognosis. Environ Mol Mutagen. 2019; 60(2):168-73. [crossref] [PubMed]
13.
Rothfu A, Schutz P, Bochum S, Volm T, Eberhardt E, Rolf Kreienberg, et al. Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res. 2000;60(2):390 94.
14.
Dey P, Samantha S, Susheilia S. Micronucleus assay in buccal smears in breast carcinoma patients. Diagn Cytopathol. 2012;40(8):664 66. [crossref] [PubMed]
15.
Hemalatha A, Suresh TN, Harendra Kumar ML. Micronuclei in breast aspirates. Is scoring them helpful? J Can Res Ther. 2014;10:309-11. [crossref] [PubMed]
16.
Sylvia MT, Baskaran L, Bhat RV. Micronucleus study on breast cytology aspirate smears and its diagnostic utility. J Cytol. 2018;35(1):22-26. [crossref] [PubMed]
17.
Mangam SN, Deshmukh AV, Shivkumar VB. Role of micronucleus assay as an indicator of chromosomal instability in aspirates of breast carcinoma. J Cancer Res Pract. 2021;8(1):20-25. [crossref]
18.
Robinson IA, McKee G, Nicholson A, D Arcy J, Jackson PA, Cook MG, et al. Prognostic value of cytological grading of fine needle aspirates from breast carcinomas. Lancet. 1994;343(8903):947-49. [crossref] [PubMed]
19.
Patino-Garcia B, Hoegel J, Varga D, Hoehne M, Michel I, Jainta S, et al. Scoring variability of micronuclei in binucleated human lymphocytes in a case-control study. Mutagenesis. 2006;21(3):191-97. [crossref] [PubMed]
20.
Field AS, Raymond WA, Rickard M, Arnold L, Brachtel EF, Chaiwun B, et al. The international academy of cytology Yokohama system for reporting breast fine-needle aspiration biopsy cytopathology. Acta Cytol. 2019;63:257-73. [crossref] [PubMed]
21.
Rahman N, Stratton MR. The genetics of breast cancer susceptibility. Annu Rev Genet. 1998; 32:95-21. [crossref] [PubMed]
22.
Lingle WL, Barrett SL, Negron VC, D’Assoro AB, Boeneman K, Liu W, et al. Centrosome amplification drives chromosomal instability in breast tumor development. Proceedings of the National Academy of Sciences. 2002;99:1978-83. [crossref] [PubMed]
23.
Bertwistle D, Ashworth A. Functions of the BRCA1 and BRCA2 genes. Curr Opin Genet Dev. 1998;8:14-20. [crossref] [PubMed]
24.
Hsu LC, White RL. BRCA1 is associated with the centrosome during mitosis. Proc Natl Acad Sci U.S.A.1998;95:12983-88. [crossref] [PubMed]
25.
Welcsh PL, Owens KN, King MC. Insights into the functions of BRCA1 and BRCA2. Trends Genet. 2000;16(2):69-74. [crossref] [PubMed]
26.
Ban S, Shinohara T, Hirai Y, Moritaku Y, Cologne JB, MacPhee DG, et al. Chromosomal instability in BRCA1- or BRCA2-defective human cancer cells detected by spontaneous micronucleus assay. Mutat Res. 2001;474(1-2):15-23. [crossref] [PubMed]
27.
Samanta S, Dey P, Nijhawan R. The role of micronucleus scoring in fine needle aspirates of ductal carcinoma of the breast. Cytopathology. 2011;22(2):111 14. [crossref] [PubMed]
28.
Meel M, Sahu I, Kumar M. Micronucleus scoring in breast cytology as a diagnostic tool to assess genotoxic changes. Indian J Pathol Microbiol. 2022;65:223-25.
29.
Nersesyan A, Kundi M, Atefie K, Hermann SR, Knasmuller S. Effect of staining procedures on the results of micronucleus assays with exfoliated oral mucosa cells. Cancer Epidemiol Biomarkers Prev. 2006;15:1835 40. [crossref] [PubMed]
30.
Metgud R, Neelesh BT. Effect of staining procedures on the results of micronucleus assay in the exfoliated buccal mucosal cells of smokers and nonsmokers: A pilot study. J Cancer Res Ther. 2018;14(2):372-76.

DOI and Others

DOI: 10.7860/JCDR/2022/49784.16810

Date of Submission: Apr 06, 2021
Date of Peer Review: Jun 14, 2021
Date of Acceptance: Jun 28, 2022
Date of Publishing: Aug 01, 2022

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Apr 09, 2022
• Manual Googling: Jun 06, 2022
• iThenticate Software: Jul 05, 2022 (7%)

ETYMOLOGY: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com